GBMM: A graph-based multimodal Mamba model for response prediction in patients with esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy.
OBJECTIVE: Neoadjuvant immunochemotherapy (NICT) can improve outcomes in advanced esophageal squamous cell carcinoma, but its efficacy varies significantly among patients. Further validation on larger multicenter prospective cohorts is required before its potential clinical utility can be established.
OBJECTIVE: Neoadjuvant immunochemotherapy (NICT) can improve outcomes in advanced esophageal squamous cell carcinoma, but its efficacy varies significantly among patients. Further validation on larger multicenter prospective cohorts is required before its potential clinical utility can be established.
What the study was
- Study design
- Multicenter Study
- Population
- n=274
- Sample size
- 274
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- International journal of medical informatics
Why it surfaced
Scored 8/10 (Multicenter Study; novelty=2, relevance=2, design_quality=2, population_or_unmet_need=2). HIGH priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.